US efforts to scrutinise overseas drug manufacturing could expose Europe’s role in supplying FDA-approved innovator and biosimilar drugs.
Resilience and Lilly have invested $750m to boost production of Lilly’s KwikPen to boost the US supply of diabetes and obesity medicines.
Cell and gene therapy manufacturers are partnering with specialist technology companies to address the challenges associated with scaling complex therapies.
AbbVie's Rinvoq, Pfizer and BioNTech's Comirnaty and Incyte's Opzelura have all received their own EU drug regulatory approvals this week.
Synlogic and Caldera Therapeutics have signed a definitive merger agreement aimed at combining in an all-stock transaction.
Amgen has received a positive opinion from the EMA’s CHMP for Repatha supporting its broader use prior to a first heart attack or stroke.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results